Embattled commercialisation firm NetScientific is closing two medical diagnostics spinouts from UCLA after both failed to attract external funding.

Commercialisation firm NetScientific is to wind down two of its US-based portfolio companies, Wanda and Vortex Biosciences, both spinouts of University of California, Los Angeles (UCLA) focused on digital health and cancer diagnostics respectively. The pair were identified as targets for efficiencies in a strategic review published by NetScientific on February 15 on account of…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.